07
Aug

In this week’s EuroBiotech Report, Roche took another step back into RNA, striking a $450 million (€335 million) deal to acquire Santaris Pharma and committing to making the Danish biotech’s lab its RNA therapeutics research unit. And more.

…read more

Source: Roche commits to Danish RNA lab, £3B London incubator hits go, Biotechs in post-IPO slump

    

0 No comments